My Health Hospitals logo

General Medicine

Ozempic Side Effects

General Medicine

OZEMPIC • SEMAGLUTIDE • 2026 GUIDE

Ozempic Side Effects in 2026: Common & Serious Risks, Safety Guide

Ozempic (semaglutide) is a prescription GLP-1 receptor agonist used for specific medical indications. Gastrointestinal symptoms are common, while pancreatitis, gallbladder disease, kidney injury from dehydration, diabetic retinopathy complications, severe gastrointestinal reactions and serious allergic reactions are among the important risks listed in current prescribing information.

Quick Answer: What Are the Main Ozempic Side Effects?

The most common Ozempic side effects are nausea, vomiting, diarrhoea, abdominal pain and constipation. More serious problems can include acute pancreatitis, gallbladder disease, diabetic retinopathy complications, acute kidney injury related to volume depletion, severe gastrointestinal adverse reactions and serious hypersensitivity reactions. The current FDA label also contains a boxed warning about thyroid C-cell tumors based on rodent data; whether this risk applies to humans is unknown.

Found this medical guide helpful?

Add My Health Hospitals as a Preferred Source on Google to see more of our latest health information.

2026 evidence update: This page uses the FDA Ozempic prescribing information revised in May 2026. Product indications and labeling can differ by country, so patients in India should also follow the locally applicable prescription and regulatory information provided by their doctor.

What Is Ozempic and How Does It Work?

Ozempic is the brand name for semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It helps lower blood glucose by increasing insulin secretion when blood glucose is elevated and reducing glucagon secretion. It also slows gastric emptying and can reduce appetite.

In the current U.S. FDA label, Ozempic is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It also has cardiovascular and kidney-risk reduction indications for specific adults with type 2 diabetes and established cardiovascular disease or chronic kidney disease.

Common Ozempic Side Effects

NauseaOne of the most frequently reported adverse reactions.
VomitingCan contribute to dehydration if persistent.
DiarrhoeaMay lead to fluid loss if severe.
Abdominal PainAbdominal discomfort is a listed common reaction.
ConstipationChanges in gastrointestinal motility can affect bowel movements.
Reduced AppetiteMay occur as part of semaglutide's GLP-1 effects.

Why Does Ozempic Cause Nausea?

Semaglutide slows gastric emptying and changes appetite and gastrointestinal signalling. These effects can contribute to nausea and other digestive symptoms. Gastrointestinal adverse reactions are particularly relevant during treatment initiation and dose escalation.

If nausea is persistent, severe or prevents you from keeping fluids down, contact your doctor rather than changing or stopping the dose yourself.

Serious Ozempic Side Effects You Should Know

Potential problemWarning symptomsWhat to do
Acute pancreatitisSevere or persistent upper abdominal pain, sometimes extending to the back, with or without vomiting.Seek urgent medical assessment. The FDA label says Ozempic should be discontinued if pancreatitis is suspected.
Gallbladder diseaseUpper-right or upper abdominal pain, fever, nausea or jaundice.Prompt medical evaluation may be needed.
Severe gastrointestinal reactionsPersistent vomiting, severe abdominal symptoms or inability to tolerate food and fluids.Contact your doctor promptly. Ozempic is not recommended in people with severe gastroparesis.
Acute kidney injury from volume depletionReduced urination, weakness or dizziness after significant vomiting or diarrhoea.Seek medical advice, especially if fluid intake is poor or symptoms are worsening.
Serious allergic reactionSwelling of the face, lips, tongue or throat, hives or trouble breathing.Seek emergency medical care immediately.
Diabetic retinopathy complicationsNew or worsening vision changes.Contact your doctor or eye-care professional promptly.

Ozempic and the Thyroid C-Cell Tumor Warning

The current FDA prescribing information carries a boxed warning for thyroid C-cell tumors. In rodents, semaglutide caused thyroid C-cell tumors. It is unknown whether Ozempic causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans.

Ozempic is contraindicated for people with a personal or family history of MTC or people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Persistent neck swelling or a neck mass, trouble swallowing, trouble breathing or persistent hoarseness should be medically assessed.

Can Ozempic Cause Pancreatitis?

Acute pancreatitis has been observed with GLP-1 receptor agonists, including Ozempic. Severe or persistent abdominal pain, especially when accompanied by vomiting, requires prompt medical evaluation.

Can Ozempic Cause Gallbladder Problems?

Acute gallbladder disease is included in the Ozempic warnings. Gallstones and inflammation of the gallbladder may require evaluation if symptoms suggest a biliary problem. Upper abdominal pain with fever, vomiting or jaundice should not be ignored.

Ozempic and Diabetic Retinopathy

Diabetic retinopathy complications were reported in an Ozempic clinical trial. The FDA label advises monitoring patients with a history of diabetic retinopathy for progression. Rapid improvement in glucose control can be associated with temporary worsening of diabetic retinopathy in some settings.

Urgent eye symptoms: Sudden or significant changes in vision should be assessed promptly.

Can Ozempic Cause Kidney Problems?

Acute kidney injury can occur, particularly when significant vomiting or diarrhoea causes dehydration and volume depletion. Seek medical assessment if fluid intake is poor, urine output falls significantly or symptoms are worsening.

Does Ozempic Cause Low Blood Sugar?

The risk of hypoglycemia increases when Ozempic is used with insulin or an insulin secretagogue such as a sulfonylurea. Medication adjustments may be required under medical supervision. Symptoms can include sweating, shakiness, hunger, dizziness, confusion and weakness.

Ozempic and Severe Gastroparesis

Ozempic delays gastric emptying and can cause gastrointestinal adverse reactions. The current FDA label says Ozempic is not recommended in patients with severe gastroparesis. Persistent vomiting, early fullness, marked bloating or difficulty maintaining nutrition and hydration require medical assessment.

Ozempic Side Effects After Increasing the Dose

Gastrointestinal symptoms may become more noticeable when the dose is increased. The FDA prescribing information uses gradual dose escalation to reduce gastrointestinal adverse reactions. Do not increase the dose faster than prescribed, and do not make dose changes based on online advice.

How to Manage Mild Ozempic Side Effects

Can You Stop Ozempic Suddenly?

Do not stop Ozempic or change the dose without discussing it with the prescribing clinician. If it is being used to manage type 2 diabetes, stopping treatment may worsen glucose control. The best transition depends on the reason for treatment, current glucose levels, other medicines and individual risk factors.

Ozempic for Weight Loss: Important Label Difference

Ozempic contains semaglutide, but semaglutide products do not all have the same approved indications. The current U.S. Ozempic label covers specific type 2 diabetes-related indications; chronic weight-management indications are associated with other semaglutide labeling. Product indications can differ by country. Patients should not assume that an Ozempic prescription for weight loss is equivalent to a locally approved weight-management indication.

WHO's guidance supports GLP-1 therapies as one component of long-term obesity management for adults with obesity, alongside lifestyle and health-professional support. It does not recommend these medicines for everyone and excludes pregnant women from that guideline.

Ozempic and Pregnancy

The current U.S. prescribing information recommends discontinuing Ozempic in women at least 2 months before a planned pregnancy because semaglutide has a long washout period. Pregnancy-related decisions should be discussed with the treating doctor.

What About Compounded Semaglutide?

Compounded semaglutide is not the same as an FDA-approved Ozempic pen. The FDA has reported dosing errors and adverse events with compounded injectable semaglutide products, including gastrointestinal effects, dehydration, pancreatitis and gallstones. Patients should verify the exact product and dose with a qualified healthcare professional.

When Should You Seek Emergency Care?

Who Should Discuss Ozempic Safety With a Doctor Before Treatment?

Ozempic Side Effects in Hyderabad

If you are using semaglutide for diabetes and are experiencing nausea, vomiting, abdominal pain, constipation, diarrhoea, dizziness, vision changes or other new symptoms, a General Medicine or Diabetology consultation can help assess whether the symptoms are medication-related and whether treatment changes are appropriate.

My Health Hospitals lists Dr. Ch. Srujith as a General Physician & Diabetologist at Kukatpally, Hyderabad, with MBBS and MD – General Medicine. The supplied hospital profile lists 11 years of overall experience and appointment phone +91 9111674111; current availability should be confirmed before visiting.

Medically Reviewed By

General Medicine & DiabetologyMedical Review
Dr. Ch. Srujith, General Physician and Diabetologist

Dr. Ch. Srujith

MBBS, MD – General Medicine | General Physician & Diabetologist

General Medicine physician at My Health Hospitals, Kukatpally, Hyderabad, with adult medical and diabetes care practice.

Specialty: Internal Medicine / General Medicine

Location: Kukatpally, Hyderabad

Listed experience: 11 years overall; confirm current profile details

Appointment: +91 9111674111

Found this medical guide helpful?

Add My Health Hospitals as a Preferred Source on Google to see more of our latest health information.

Frequently Asked Questions About Ozempic Side Effects

The most common adverse reactions listed in the current FDA label are nausea, vomiting, diarrhoea, abdominal pain and constipation.
Yes. Nausea is one of the most frequently reported Ozempic adverse reactions and may be more noticeable when treatment starts or the dose is increased.
Yes. Vomiting is a common adverse reaction. Persistent vomiting can cause dehydration and should be discussed with a clinician.
Yes. Constipation is listed among common Ozempic adverse reactions. Persistent or severe constipation should be medically assessed.
Yes. Diarrhoea is a common adverse reaction and can lead to dehydration if severe or persistent.
Acute pancreatitis has been observed with GLP-1 receptor agonists including Ozempic. Severe or persistent abdominal pain needs urgent medical assessment.
Pancreatitis may cause severe or persistent upper abdominal pain that can extend to the back. Prompt clinical assessment is important.
Acute gallbladder disease is included in the Ozempic warnings. Upper abdominal pain with fever, vomiting or jaundice should be assessed.
Diabetic retinopathy complications have been reported. New or worsening vision changes should be assessed promptly.
The risk of hypoglycemia is higher when Ozempic is combined with insulin or an insulin secretagogue such as a sulfonylurea.
Ozempic can cause gastrointestinal adverse reactions and is not recommended in patients with severe gastroparesis.
Yes. The current FDA label has a boxed warning about thyroid C-cell tumors based on rodent studies; human risk is unknown.
Duration varies. Mild gastrointestinal symptoms may improve as the body adjusts, but persistent or severe symptoms should be reviewed.
Gastrointestinal symptoms may become more noticeable during dose escalation. The FDA label uses gradual dose increases to reduce gastrointestinal adverse reactions.
Acute kidney injury can occur, particularly when vomiting or diarrhoea causes dehydration and volume depletion.
Do not stop or change Ozempic without discussing it with your prescribing clinician. Stopping can worsen glucose control in people using it for diabetes.
Pregnancy requires individualized medical advice. The current FDA prescribing information recommends discontinuing Ozempic at least 2 months before a planned pregnancy.
Approved indications depend on the country and product. In current U.S. labeling, Ozempic is indicated for specific type 2 diabetes-related uses; chronic weight-management indications are associated with other semaglutide labeling.
Ozempic is contraindicated in people with a personal or family history of medullary thyroid carcinoma, MEN 2 or a serious hypersensitivity reaction to semaglutide or its ingredients.
Seek urgent care for severe or persistent abdominal pain, severe allergic symptoms, significant dehydration, very low urine output, sudden major vision changes, loss of consciousness or rapidly worsening symptoms.

Having Persistent Ozempic Side Effects?

Severe abdominal pain, repeated vomiting, dehydration, vision changes or other concerning symptoms should be assessed rather than managed through online advice alone.

My Health Hospitals – Kukatpally: +91 9111674111

Medical disclaimer: This article is for general educational information and does not replace a clinical consultation. Medication choice, dose changes and treatment decisions should be made with a qualified healthcare professional. Product labels can change, and local prescribing requirements may differ from U.S. information.

Our Branch Locations

Find the Best Hospital Near You

My Health Hospitals – Kukatpally

H.No 15-24-212, MIG-212, Rd Number 1, K P H B Phase 1, Kukatpally, Hyderabad, Telangana 500072

Get Directions

My Health Hospitals – Tarnaka

H.No:-12-5-30, WhiteHouse, Moula Ali Rd, South Lalaguda, Tarnaka, Secunderabad, Telangana 500017

Get Directions
My Health Assistant